• Username (E-mail)
  • Password
Dow 19,913 0.6%  EStoxx50 3,282 0.3%  Nikkei 18,788 -0.6%  EUR 1.0734 -0.3% 
Nasdaq 5,601 0.9%  FTSE100 7,150 0.0%  Yen 113.7880 1.0%  Oil 55.3 -0.1% 
S&P500 2,280 0.7%  DAX 11,595 0.4%  GBP 1.2516 -0.1%  Gold 1,210 -0.8% 

Hikma Pharmaceuticals share [ISIN: GB00B0LCW083]

Realtimequote Hikma Pharmaceuticals PLCShs in GBP

Exchange Market
19.01
Last
0
Volume
Time 11:29 AM
01/24/2017 11:29:55 AM UTC-0500
activate push

Stock Price Hikma Pharmaceuticals PLCShs in GBP

Activate push
19.11 GBP -0.18 GBP -0.93 %
Trade Time 4:35 PM Trade Date 1/24/2017
Daily High 19.31 Open 19.30
Daily Low 18.96 Prev. Close 19.29
52-week High 27.03 Volume (Qty.) 741,124
52-week Low 15.75 Market Cap (USD) 5.82 B
52-week Perf.
Exchange
The price of 19.11 GBP on the exchange London equals a price of 23.92 USD at the current exchange rate for GBP/USD.

Analyst Opinions for Hikma Pharmaceuticals PLCShs

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
10/10/11
Hikma Pharmaceuticals Citigroup Corp.

Moody's Rating for Hikma Pharmaceuticals PLCShs

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating
Rating Update
Date of Rating
Rating Office -

Profile Hikma Pharmaceuticals PLCShs

Company Profile
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment offers selling of branded generics and in-licensed patented products. The Injectables segment includes manufacturing of sterile injectables. The Generics segment focuses on the U.S. market for oral generics. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd. and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Saaid Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.
pagehit

Add or Edit Instrument

Hikma Pharmaceuticals Chart - 1 Year - LSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: LSE
  • Chart Options

Estimates for Hikma Pharmaceuticals

2015 2016e 2017e
Dividend 0.22 0.18 0.23
Dividend Yield in % 0.94 0.92 1.18
P/E Ratio 24.04 23.27 16.82
EPS 0.97 0.84 1.16

Hikma Pharmaceuticals Key Figures

Market Cap (USD) 5.82 B
Free Float in % 57.02
Number of Shares (Mio.) 239.95
Cash Flow per Share 1.25
Book Value per Share 4.58
60-Days Volatility 42.05
P/B Ratio 5.06

Base Data Hikma Pharmaceuticals

Symbol
ISIN GB00B0LCW083
Indices FTSE 100

About the Company Hikma Pharmaceuticals

Country Great Britain

Hikma Pharmaceuticals Historical Prices

01/22/2017
01/22/2017 06:00:00 PM UTC-0500
19.29 515,183
01/19/2017
01/19/2017 06:00:00 PM UTC-0500
19.38 492,322
01/18/2017
01/18/2017 06:00:00 PM UTC-0500
19.43 473,601
01/17/2017
01/17/2017 06:00:00 PM UTC-0500
19.56 941,991
01/16/2017
01/16/2017 06:00:00 PM UTC-0500
19.14 460,480

Hikma Pharmaceuticals Peer Group

Hikma Pharmaceuticals 19.01
-1.3%